Listen

Description

Download
In this episode, Kyle interviews Dr. Alexander Belser, a Clinical Researcher who has done a variety of works in the psychotherapy and psychedelic fields, helping patients heal from depression, OCD, suicide, and other illnesses, all while focusing on gender neutrality and equality. In this episode, they cover topics on privilege, inclusivity and recommendations for the psychedelic space.

3 Key Points:

  1. Privilege is commonly seen in therapist roles and as well in an individual's access to treatment. It's important for the psychedelic community to be vocal about privilege and be inclusive of all types of people, all repressed groups.
  2. Psychedelics have the power to help people come to terms with their own sexuality, as well as become accepting of other individuals sexual identification.
  3. In order to see more equality in the psychedelic space, we need to confront structural heterosexism and transfobia, retire the male/female therapy diad, and develop acknowledgement in the psychedelic world of the stresses that LGBTQ people face.

Support the show

Navigating Psychedelics

Navigating Psychedelics: Lessons on Self-Care and Integration


Trip Journal                                               Integration Workbook


Show Notes

About Alexander

Queering Psychedelics

Privilege and Inclusivity

Recommendations

Mystical Experience

Final Thoughts

Links

Alexander's website
Center for Breakthroughs


About Dr. Alexander Belser

Alexander Belser, Ph.D., is a Clinical Research Fellow and clinical supervisor at Yale University. He is the Co-Investigator of two studies at Yale exploring psychedelic-assisted psychotherapy to treat OCD and depression. His research with sexual minority people has focused on preventing suicide among adolescents and on the protective role of gay-straight alliances for students. Dr. Belser was a founding member of the Psychedelic Research Group at NYU in 2006, and he is currently an Adjunct Faculty member in NYU's graduate program in Counseling Psychology. He has been a researcher on various psychedelic studies of depression, anxiety, OCD, addiction, trauma, and among religious leaders. He is a study therapist for the MAPS study of MDMA-assisted psychotherapy for PTSD. Dr. Belser serves as a peer reviewer and has published peer-reviewed articles on topics such as psychedelic mysticism, altruism, patient experiences in psilocybin-assisted psychotherapy, cancer and psychedelic therapy, case studies, psilocybin treatment and posttraumatic growth (forthcoming).